Japan has had a programme of colorectal cancer screening with immunochemical faecal occult blood testing since 1992. Participation rates are around 17%. Approximately 7% of subjects test positive and, of these, around 60% comply with the request to undergo further diagnostic testing. Colorectal cancer rates have been increasing rapidly in Japan in recent decades, and there is an urgent need to improve participation rates.
References
1.
KuroishiT, HiroseK, TakezakiT, et al. Cancer mortality in Japan (1950-2000). In: OoshimaA, KuroishiT, TazimaK, eds. Cancer Statistics Morbidity/Morbidity/Prognosis. Tokyo: Shinohara Publishing Ltd, 2004;2–96.
2.
OhnoY, NakamuraK, MurataK, et al. Estimation of cancer incidence in Japan in the Future. OoshimaA, KuroishiT, TazimaK, eds. Cancer Statistics Morbidity/Morbidity/Prognosis. Tokyo: Shinohara Publishing Ltd, 2004;201–18.
3.
SaitoH.Screening for colorectal cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res1996;87:1011–24.
4.
MandelJS, BondJH, ChuchTR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med1993;328:1365–71.
5.
KronborgO, FengerC, OlesenJ, et al. Randomized study of screening for colorectal cancer with fecal-occult-blood test. Lancet1996;348:1467–71.
6.
HardcastleJD, ChamberlainJO, RobinsonMHE, et al. Randomized controlled trial of fecal-occult-blood screening for colorectal cancer. 1996;348:1472–7.
7.
HisamichiS, FukaoA, FujiiY, et al. Mass screening for colorectal cancer in Japan. Cancer Detect Prev1991;15:351–6.
8.
NakajimaM, SaitoH, SomaY, et al. Prevention of advanced colorectal cancer by screening using the immunochemical fecal occult blood test: a case-control study. Br J Cancer2003;89:23–8.
9.
The Committee for a Nationwide Totaling of Mass screening for Gastrointestinal Cancer. A nationwide totaling of mass screening for gastrointestinal cancer. J Gastroenterol Mass Surv2005;43:54–73.
10.
HiwatashiN, MorimotoT, FukaoA, et al. An evaluation of mass screening using fecal occult blood test for colorectal cancer in Japan. Jpn J Cancer Res1993;84:1110–2.
11.
SaitoH, SomaY, KoedaJ, et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test - A case-control study. Int J Cancer1995;61:465–469.
12.
ZappaM, CastiglioneG, GrazziniG, et al. Effect of fecal occult blood testing on colorectal mortality. Results of a population-based case-control study in the district of Florence, Italy. Int J Cancer1997;73:208–10.
13.
SaitoH, SomaY, NakajimaM, et al. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test. Oncol Rep2000;7:815–19.
